MoreyABlinderMD
Hematology • Saint Louis, MOClotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias
Associate Professor of Medicine, Washington University
Dr. Blinder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-7216Fax+1 314-362-8813
Education & Training
University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1984 - 1987- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1981 - 1984
Saint Louis University School of MedicineClass of 1981
Certifications & Licensure
MO State Medical License 1990 - 2025
FL State Medical License 2012 - 2017
WA State Medical License 1984 - 1989
IL State Medical License 1981 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- St. Louis Magazine: Top Doctors Castle Connolly, 2001
- Join now to see all
Clinical Trials
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
Publications & Presentations
PubMed
- 336 citationsClinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populationsAlan E. Mast, Morey A. Blinder, Ann M. Gronowski, Cara Chumley, Mitchell G. Scott
Clinical Chemistry. 1998-01-01 - 419 citationsPharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein ThrombosisSuresh Vedantham, Samuel Z. Goldhaber, Jim A. Julian, Susan R. Kahn, Michael R. Jaff
The New England Journal of Medicine. 2017-12-06 - 34 citationsRituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapyJoshua J. Field, Timothy S. Fenske, Morey A. Blinder
Haemophilia. 2007-01-01
Press Mentions
Plasma You Sell in East Kansas City Could End up in Medicine an Ocean AwayJune 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
